| Literature DB >> 31423260 |
Na Wang1,2, Qingting Bu3, Qingqing Liu1,4, Jin Yang1,4, Hairong He1, Jie Liu2, Xuequn Ren5,6, Jun Lyu1.
Abstract
Numerous studies have shown that marital status may be a prognostic factor in various malignancies, but little is known about its effect on duodenal adenocarcinoma. The aim of the present study was to determine the association between marital status and survival in patients with duodenal adenocarcinoma. The Surveillance, Epidemiology and End Results database was utilized to analyze 2,018 patients who had been diagnosed with duodenal adenocarcinoma between January 2004 and December 2015. Kaplan-Meier and Cox regression analyses were also used to determine the impact of marital status on overall survival (OS) and cause-specific survival (CSS). The 5-year OS rate was higher in married patients (32.6%) compared with unmarried (26.8%) patients (P<0.001), as was the 5-year CSS rate (38.8 vs. 33.7%; P<0.001). Multivariate analysis demonstrated that marital status was an independent prognostic factor for duodenal adenocarcinoma, with married patients having improved OS (P<0.001) and CSS (P=0.001) compared with unmarried patients. Subgroup analysis showed that marital status played a role in the survival of patients at American Joint Committee on Cancer Tumor-Node-Metastasis stage I, but not of patients at stages II, III or IV. The survival outcomes for duodenal adenocarcinoma are improved in married patients compared with those in unmarried patients. Therefore, attention should be paid to the impact of social factors and socio-economic factors on unmarried patients, in order to improve their survival outcomes.Entities:
Keywords: Surveillance Epidemiology and End Results; cause-specific survival; duodenal adenocarcinoma; marital status; overall survival
Year: 2019 PMID: 31423260 PMCID: PMC6607043 DOI: 10.3892/ol.2019.10475
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Baseline demographic and tumor characteristics of patients in the Surveillance, Epidemiology and End Results database.
| Characteristic | Total | Married, n (%) | Unmarried, n (%) | P-value |
|---|---|---|---|---|
| Patients, n (%) | 2,018 (100.00) | 1,227 (60.80) | 791 (39.20) | |
| Median age (25th-75th percentile), years | 68 (58–76) | 67 (57–75) | 69 (59–79) | <0.001 |
| Year of diagnosis, n (%) | 0.053 | |||
| 2004–2006 | 409 (20.27) | 262 (21.35) | 147 (18.58) | |
| 2007–2009 | 466 (23.09) | 261 (21.27) | 205 (25.92) | |
| 2010–2012 | 556 (27.55) | 351 (28.61) | 205 (25.92) | |
| 2013–2015 | 587 (29.09) | 353 (28.77) | 234 (29.58) | |
| Sex, n (%) | <0.001 | |||
| Female | 948 (46.98) | 450 (36.67) | 498 (62.96) | |
| Male | 1,070 (53.02) | 777 (63.33) | 293 (37.04) | |
| Ethnicity, n (%) | <0.001 | |||
| Caucasian | 1,501 (74.38) | 974 (79.38) | 527 (66.62) | |
| African descent | 358 (17.74) | 156 (12.71) | 202 (25.54) | |
| Other | 159 (7.88) | 97 (7.91) | 62 (7.83) | |
| Grade, n (%) | 0.357 | |||
| I | 376 (18.63) | 216 (17.60) | 160 (20.23) | |
| II | 908 (45.00) | 569 (46.37) | 339 (42.86) | |
| III | 705 (34.94) | 425 (34.64) | 280 (35.40) | |
| IV | 29 (1.44) | 17 (1.39) | 12 (1.52) | |
| AJCC TNM stage, n (%) | <0.001 | |||
| I | 406 (20.12) | 217 (17.69) | 189 (23.89) | |
| II | 387 (19.18) | 248 (20.21) | 139 (17.57) | |
| III | 609 (30.18) | 406 (33.09) | 203 (25.66) | |
| IV | 616 (30.53) | 356 (29.01) | 260 (32.87) | |
| Surgery, n (%) | <0.001 | |||
| Yes | 1,240 (61.45) | 790 (64.38) | 450 (56.89) | |
| No | 778 (38.55) | 437 (35.62) | 341 (43.11) |
AJCC, American Joint Committee on Cancer; TNM, Tumor-Node-Metastasis.
Figure 1.Survival curves in patients with duodenal adenocarcinoma comparing married and unmarried patients. (A) Overall survival. (B) Cause-specific survival. Cum, cumulative.
Univariate and multivariate survival analysis of OS in patients with duodenal adenocarcinoma.
| Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|
| Characteristic | 5-year OS, % | HR | 95% CI | P-value | HR | 95% CI | P-value |
| Year of diagnosis | |||||||
| 2004–2006 | 26.1 | Reference | Reference | ||||
| 2007–2009 | 25.7 | 0.948 | 0.814–1.103 | 0.488 | 0.955 | 0.819–1.115 | 0.562 |
| 2010–2012 | 34.0 | 0.770 | 0.660–0.898 | 0.001 | 0.852 | 0.729–0.995 | 0.043 |
| 2013–2015 | N/A | 0.772 | 0.652–0.914 | 0.003 | 0.805 | 0.679–0.955 | 0.013 |
| Age, years | |||||||
| ≤58 | 46.0 | Reference | Reference | ||||
| 59–75 | 31.3 | 1.519 | 1.312–1.760 | <0.001 | 1.544 | 1.330–1.791 | <0.001 |
| >75 | 12.8 | 2.753 | 2.358–3.215 | <0.001 | 2.585 | 2.199–3.039 | <0.001 |
| Sex | |||||||
| Female | 33.4 | Reference | Reference | ||||
| Male | 27.6 | 1.129 | 1.010–1.261 | 0.032 | 1.176 | 1.047–1.322 | 0.006 |
| Race | |||||||
| Caucasian | 30.8 | Reference | Reference | ||||
| African descent | 29.7 | 1.038 | 0.898–1.199 | 0.614 | 1.068 | 0.920–1.239 | 0.387 |
| Other | 26.0 | 0.976 | 0.789–1.206 | 0.820 | 0.892 | 0.721–1.105 | 0.296 |
| Marital status | |||||||
| Married | 32.6 | Reference | Reference | ||||
| Unmarried | 26.8 | 1.303 | 11.651.457 | <0.001 | 1.259 | 1.118–1.419 | <0.001 |
| Grade | |||||||
| I | 56.0 | Reference | Reference | ||||
| II | 29.0 | 2.073 | 1.723–2.494 | <0.001 | 1.552 | 1.278–1.884 | <0.001 |
| III | 19.1 | 2.963 | 2.457–3.547 | <0.001 | 2.105 | 1.722–2.572 | <0.001 |
| IV | 22.3 | 2.740 | 1.731–4.336 | <0.001 | 2.349 | 1.473–3.745 | <0.001 |
| AJCC TNM stage | |||||||
| I | 53.0 | Reference | Reference | ||||
| II | 36.3 | 1.433 | 1.171–1.752 | <0.001 | 1.451 | 1.171–1.798 | 0.001 |
| III | 36.4 | 1.386 | 1.153–1.667 | 0.001 | 1.722 | 1.405–2.110 | <0.001 |
| IV | 6.2 | 4.375 | 3.665–5.223 | <0.001 | 2.427 | 1.994–2.953 | <0.001 |
| Surgery | |||||||
| Yes | 46.4 | Reference | Reference | ||||
| No | 3.9 | 4.610 | 4.097–5.188 | <0.001 | 3.399 | 2.914–3.964 | <0.001 |
OS, overall survival; HR, hazard ratio; CI, confidence interval; AJCC, American Joint Committee on Cancer; N/A, not available; TNM, Tumor-Node-Metastasis.
Univariate and multivariate survival analysis of CSS in patients with duodenal adenocarcinoma.
| Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|
| Characteristic | 5-year CSS, % | HR | 95% CI | P-value | HR | 95% CI | P-value |
| Year of diagnosis | |||||||
| 2004–2006 | 32.0 | Reference | Reference | ||||
| 2007–2009 | 32.9 | 0.934 | 0.792–1.103 | 0.421 | 0.985 | 0.810–1.133 | 0.612 |
| 2010–2012 | 40.1 | 0.790 | 0.669–0.932 | 0.005 | 0.901 | 0.762–1.065 | 0.221 |
| 2013–2015 | N/A | 0.766 | 0.639–0.919 | 0.004 | 0.823 | 0.685–0.989 | 0.038 |
| Age, years | |||||||
| ≤58 | 49.7 | Reference | Reference | ||||
| 59–75 | 38.1 | 1.377 | 1.179–1.609 | <0.001 | 1.390 | 1.187–1.627 | <0.001 |
| >75 | 20.2 | 2.478 | 2.102–2.921 | <0.001 | 2.325 | 1.958–2.760 | <0.001 |
| Sex | |||||||
| Female | 39.4 | Reference | Reference | ||||
| Male | 34.5 | 0.102 | 0.978–1.242 | 0.111 | 1.123 | 0.990–1.274 | 0.071 |
| Race | |||||||
| Caucasian | 36.5 | Reference | Reference | ||||
| African descent | 37.5 | 0.969 | 0.827–1.136 | 0.697 | 0.982 | 0.833–1.156 | 0.825 |
| Other | 38.9 | 0.885 | 0.698–1.121 | 0.310 | 0.815 | 0.642–1.034 | 0.092 |
| Marital status | |||||||
| Married | 38.8 | Reference | Reference | ||||
| Unmarried | 33.7 | 1.273 | 1.128–1.436 | <0.001 | 1.236 | 1.086–1.407 | <0.001 |
| Grade | |||||||
| I | 69.5 | Reference | Reference | ||||
| II | 35.0 | 2.690 | 2.153–3.362 | <0.001 | 1.919 | 1.523–2.419 | <0.001 |
| III | 22.9 | 4.071 | 3.254–5.093 | <0.001 | 2.717 | 2.145–3.441 | <0.001 |
| IV | 23.3 | 3.923 | 2.418–6.365 | <0.001 | 3.237 | 1.979–5.294 | <0.001 |
| AJCC TNM stage | |||||||
| I | 67.3 | Reference | Reference | ||||
| II | 44.8 | 1.762 | 1.390–2.234 | <0.001 | 1.666 | 1.298–2.140 | <0.001 |
| III | 42.2 | 1.786 | 1.435–2.222 | <0.001 | 2.116 | 1.668–2.685 | <0.001 |
| IV | 7.3 | 6.143 | 4.984–7.571 | <0.001 | 3.057 | 2.435–3.838 | <0.001 |
| Surgery | |||||||
| Yes | 54.6 | Reference | Reference | ||||
| No | 5.9 | 5.163 | 4.544–5.866 | <0.001 | 3.746 | 3.165–4.434 | <0.001 |
CSS, cause-specific survival; HR, hazard ratio; CI, confidence interval; AJCC, American Joint Committee on Cancer; N/A, not available; TNM, Tumor-Node-Metastasis.
Figure 2.Survival curves in the different sex subgroups of patients with duodenal adenocarcinoma according to marital status. (A) Female OS. (B) Female CSS (C) Male OS. (D) Male CSS. OS, overall survival; CSS, cause-specific survival; Cum, cumulative.
Univariate and multivariate survival analysis of patients with duodenal adenocarcinoma based on sex.
| A, OS | |||||||
|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | ||||||
| Characteristic | 5-year survival, % | Median survival time, months | Log rank χ2 | P-value | HR | 95% CI | P-value |
| Female | 28.356 | <0.001 | |||||
| Married | 41.0 | 29 | Reference | ||||
| Unmarried | 26.6 | 12 | 1.220 | 1.024–1.454 | 0.026 | ||
| Male | 4.648 | 0.031 | |||||
| Married | 27.8 | 17 | Reference | ||||
| Unmarried | 27.0 | 12 | 1.273 | 1.078–1.503 | 0.004 | ||
| Female | 24.144 | <0.001 | |||||
| Married | 46.3 | 45 | Reference | ||||
| Unmarried | 33.0 | 15 | 1.218 | 1.009–1.470 | 0.040 | ||
| Male | 1.558 | 0.212 | |||||
| Married | 34.3 | 22 | Reference | ||||
| Unmarried | 35.0 | 17 | 1.218 | 1.014–1.463 | 0.035 | ||
OS, overall survival; CSS, cause-specific survival; HR, hazard ratio; CI, confidence interval.
Figure 3.Survival curves in different Tumor-Node-Metastasis stage subgroup patients with duodenal adenocarcinoma according to marital status. (A) Stage I OS. (B) Stage I CSS. (C) Stage II OS. (D) Stage II CSS. (E) Stage III OS. (F) Stage III CSS. (G) Stage IV OS. (H) Stage IV CSS. OS, overall survival; CSS, cause-specific survival; Cum, cumulative.
Univariate and multivariate survival analysis of patients with duodenal adenocarcinoma based on the American Joint Committee on Cancer Tumor-Node-Metastasis stage.
| A, OS | |||||||
|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | ||||||
| Characteristic | 5-year survival, % | Median survival time, months | Log rank χ2 | P-value | HR | 95% CI | P-value |
| Stage I | 19.027 | <0.001 | |||||
| Married | 61.5 | N/A | Reference | ||||
| Unmarried | 43.2 | 34 | 1.778 | 1.286–2.459 | <0.001 | ||
| Stage II | 0.707 | 0.400 | |||||
| Married | 36.0 | 31 | Reference | ||||
| Unmarried | 37.2 | 20 | 1.101 | 0.825–1.468 | 0.513 | ||
| Stage III | 3.800 | 0.051 | |||||
| Married | 38.6 | 33 | Reference | ||||
| Unmarried | 32.2 | 25 | 1.226 | 0.971–1.547 | 0.087 | ||
| Stage IV | 7.020 | 0.008 | |||||
| Married | 6.5 | 6 | Reference | ||||
| Unmarried | 5.8 | 4 | 1.176 | 0.972–1.423 | 0.096 | ||
| Stage I | 10.993 | 0.001 | |||||
| Married | 74.6 | N/A | Reference | ||||
| Unmarried | 58.4 | N/A | 1.732 | 1.162–2.583 | 0.007 | ||
| Stage II | 2.130 | 0.144 | |||||
| Married | 45.3 | 53 | Reference | ||||
| Unmarried | 43.8 | 37 | 1.255 | 0.916–1.721 | 0.157 | ||
| Stage III | 1.129 | 0.288 | |||||
| Married | 43.4 | 41 | Reference | ||||
| Unmarried | 39.6 | 31 | 1.119 | 0.867–1.445 | 0.387 | ||
| Stage IV | 7.000 | 0.008 | |||||
| Married | 7.7 | 7 | Reference | ||||
| Unmarried | 6.9 | 4 | 1.189 | 0.976–1.447 | 0.085 | ||
OS, overall survival; CSS, cause-specific survival; HR, hazard ratio; CI, confidence interval; N/A, not available. NE.Bib.